Summit Therapeutics presents a buying opportunity in the long-term. Ivonescimab looks to change the cancer care landscape.

Vera Therapeutics has an upcoming phase 3 topline readout for atacicept.

Executive Summary - Praxis is a short going into interim results. Praxis Precision Medicines is developing Ulixacaltamide, a small...

Executive Summary Immunovant will soon publish their phase 3 results for batoclimab, a monoclonal antibody developed to treat Myasthenia...

Celcuity gedatolisib phase 3 analysis for breast cancer